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doi: 10.1016/j.bpj.2010.01.006The inherently dynamic nature of proteins, encompassing
both backbone and side-chain motions, is a well established
phenomenon. This protein mobility plays a critical role in a
range of biological functions, such as the exchange of
ligands or the opening and closing of membrane channels.
Diverse demonstrations of the importance of protein flexi-
bility have been documented, for example, in the catalytic
mechanism of pathogenic thymidylate synthetase (1), and
the resistance of HIV protease (2), making advances in the
understanding of protein plasticity of widespread impor-
tance. Mobile loop structures, which often host ligand
binding sites, confer regions of particular flexibility. Exam-
ples recently identified from molecular dynamics (MD)
simulations include avian Influenza neuraminidase (3) and
Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phos-
phate reductoisomerase (4). In a similar fashion, conforma-
tional fluctuations in the Trp312 loop region at the catalytic
cleft of the Trypanosoma cruzi trans-sialidase (TcTS)
enzyme have been observed (5).
In this work, we investigate the implications of active site
plasticity on biochemical mechanism by simulating the
dynamics of intermediate steps along the sialic acid transfer
pathway in TcTS (Scheme 1). From our explicitly solvated
MD analysis, we witness varying degrees of movement of
the Trp312 loop as part of a complex, dynamic, and poten-
tially interlinked series of events involved in the catalytic
function of TcTS. Our simulations directly observe the
mechanism of expulsion of the aglycone leaving group
from the catalytic site, and, by implication, recognition of
the new acceptor substrate. This appears to be the result
from a previously undocumented molecular shovel action
by the flexible Trp312 loop.
T. cruzi is the causative agent of Chagas disease, a form
of trypanosomiasis presenting a serious health burden to
Central and South America (6). The surface-anchored
TcTS scavenges sialic acid from host glycoconjugates, and
is recognized as crucial for host cell invasion and infection(7). NMR, x-ray crystallographic, and mutagenesis studies
on TcTS (8–10) have provided valuable structural and mech-
anistic insights. Recently, mass spectrometric analysis has
confirmed a ping-pong bi-bi kinetic mechanism of sialic acid
transfer by TcTS, with formation of a covalent sialyl-enzyme
intermediate (11). The early crystallographic work found the
TcTS catalytic cleft to comprise a sialic acid binding site
and an acceptor binding site. The latter is formed by Tyr119
and Trp312, which make CH-p interactions with donor and
acceptor sugar residues adjacent to the terminal sialic acid
(9,10). The crystal structures also suggest flexibility in
the Tyr119 side-chain conformation; in the apo enzyme, the
phenolic side chain is able to point downward toward the
floor of the catalytic pocket. However, with bound substrate,
the Tyr119 side chain is oriented upwards to form a stack with
substrate (Fig. 1). Recent simulation studies (5) additionally
suggest flexibility of the Trp312 loop (residues 310 to 314) at
the mouth of the catalytic cleft, migrating between open and
closed conformations (Fig. 1). This confers further plasticity
to the apo enzyme and control over solvent exposure of the
active site.
MD simulations of I, III and IV (Scheme 1) were per-
formed based on TcTS crystal structures. The structures
are stable over the 40 ns simulations (Fig. S1 in the Support-
ing Material). Tyr119 shifts away from its stacked position for
each of the three systems studied. Similarly, for each system,
Trp312 samples conformations with significantly different c2
torsion angles. A combination of side-chain rotation with
a subtle surface loop motion enables the observed conforma-
tional opening and closing of Trp312 (Fig. 1). In particular,
our simulations suggest that vacation of lactose from the
FIGURE 1 Flexibility of the Tyr119 and Trp312 residues of TcTS
during the molecular dynamics simulation of the sialyl enzyme
covalent intermediate complexed with lactose: Tyr119 switches
from the stacked to a rotated position and Trp312 moves between
stacked and open conformations.
SCHEME 1 First step of sialyl transfer catalyzed by TcTS.
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linked to opening of the catalytic cleft.
Movement of the Trp312 residue appears to be funda-
mental to the process of ligand expulsion seen in the sialy-
lated enzyme/lactose simulation, III (Fig. 2). In the initial
pose derived from crystallography, lactose sits in the
acceptor site, forming a face-to-face stack with Trp312 and
a parallel displaced stack with Tyr119 (Fig. 2 a). This sand-
wich arrangement appears optimized to promote a reactive
orientation for the original a2,3-sialyllactose substrate
(II, Scheme 1). However, the absence of a covalent bond
between sialic acid and lactose in the sialylated enzyme
intermediate (III, Scheme 1) permits a lever-like swing of
the lactose/Trp312 stack as the Trp312 loop opens: rotation
of Tyr119 away from the stacked position at 22 ns abrogates
the lactose/Tyr119 stacking interaction (Fig. 2 b and Fig. 3 a).
This is followed by the Trp312 motion, which relocates the
lactose/Trp312 stack to a more solvent-exposed position
(Fig. 2 b and Fig. 3 b). This conformation is maintained
for over 10 ns until lactose migration out of the active site
and away from the protein surface is observed at 32 ns
(Fig. 2 c and Fig. 3 c). Of three replicate simulations of III
with differing initial velocities, two did not observe lactose
expulsion (Fig. S2), as expected from the rare nature of
this event on the timescale of the simulations.
The predicted persistence of lactose/Trp312 interactions in
the open solvent exposed pose is interesting. CH-p interac-
tions are common in carbohydrate-protein binding and are
estimated to contribute a potential energy of 2 kcal/molper interaction (12). For further evidence of the feasibility
of such water-exposed lactose-aromatic interactions, we
recorded solution phase 1H NMR spectra for the disaccha-
ride lactose with phenol added as a simple aromatic partner.
We note that previous NMR investigations into carbohy-
drate-p interactions have partnered various monosaccharides
with aromatic entities (13); however, these analyses have not
been reported for disaccharides. Complex was detected, with
spectra showing marked upfield shifts for galactose H-1,
H-3, H-4, H-5 and adjacent a-glucose H-40 (Table S1),
consistent with an aromatic shielding effect on one face of
lactose. The NMR experiments also suggest that the complex
is weakly bound, consistent with ultimate dissociation of
lactose from the enzyme.
We, therefore, surmise a dual role for Trp312. Firstly, it
assists Tyr119 in orienting substrate for sialylation of TcTS.
Secondly, due to its lever-like motion, Trp312 behaves like a
molecular shovel: it displaces donor product from the active
site following delivery of sialic acid, and, implied by theFIGURE 2 Selected steps from
along the MD trajectory of the sia-
lylated-enzyme/lactose complex,
III. (a) Initially Tyr119 is in the
stacking position and the Trp312
loop is stacked (b) At 22 ns, the
Tyr119 rotates away from the
stack, followed by a Trp312 motion
to shift the Trp312/lactose portion
of the stack (c) Full opening of
the Trp312 loop enables lactose
to vacate the active site by 32 ns.
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FIGURE 3 Dynamics of sialylated TcTS/lactose (III): time series
of (a) side-chain dihedral angle, c1, of Tyr
119; (b) intercentroid
distance between Tyr119 and Trp312 rings; and (c) distance
between centers of mass of sialic acid and lactose.
L40 Biophysical Lettersmicroscopic reversibility of MD, loads acceptor substrate
into position for subsequent molecule binding. This critical
role in orientation of acceptor may aid explanation of the
observation by Paris et al. (14) of complete abolition of
trans-sialidase activity in Trp312Ala TcTS mutant.
Due to the dynamical nature of proteins, enzyme activity
is likely to present a more complex picture than static crystal
structures may imply. Our simulations suggest that arrival,
occupancy, and departure of donor and acceptor substrates
at the catalytic cleft of TcTS is a process supported by struc-
tural fluctuations in key active site residues. Trp312 loop
flexibility appears to have a mechanistic role during sialyl
transfer, with Trp312 position and orientation acting as a lever
in discharging donor and recognizing acceptor aglycone. The
detailed computational insights into sialyl transfer obtained
here also provide much needed new avenues for structure-
based design against TcTS, an enzyme which to date has
proved stubbornly resistant to rational design attempts (15).
By building on early work developing the dynamic pharma-
cophore (16) and relaxed complex (17) methods, incorpora-
tion of receptor flexibility into molecular design of strong
binders is proving increasingly fruitful and our hope is that
this deepened structural understanding of TcTS will lend
new impetus to the design of anti-Chagas inhibitors effective
against this neglected yet devastating tropical disease.SUPPORTING MATERIAL
Two figures and one table are available at http://www.biophysj.org/biophysj/
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